Miyake Kensaku, Ibaraki Nobuhiro, Goto Yoko, Oogiya Shin, Ishigaki Junko, Ota Ichiro, Miyake Sampei
Shohzankai Medical Foundation, Miyake Eye Hospital, Nagoya, Japan.
J Cataract Refract Surg. 2003 Sep;29(9):1800-10. doi: 10.1016/s0886-3350(03)00560-1.
Many antiglaucoma eyedrops are reported to cause cystoid macular edema (CME) in aphakia and pseudophakia. We review 4 clinical and laboratory studies that compare the incidence of CME in early postoperative pseudophakia in eyes that received preserved latanoprost and timolol, nonpreserved timolol, and the preserved and nonpreserved vehicle for these drugs and looked at the morphological damage to cells and the changes in the indicators of cytokine and prostaglandin (PG) synthesis caused by latanoprost and timolol and the preservative benzalkonium chloride. Based on the findings of these studies, which indicate that the preservative causes increased synthesis of PGs and other substances and intensified postoperative inflammation, the term pseudophakic preservative maculopathy is proposed for CME caused by antiglaucoma eyedrops.
据报道,许多抗青光眼眼药水会导致无晶状体眼和人工晶状体眼发生黄斑囊样水肿(CME)。我们回顾了4项临床和实验室研究,这些研究比较了接受保存的拉坦前列素和噻吗洛尔、未保存的噻吗洛尔以及这些药物的保存和未保存赋形剂的眼在术后早期人工晶状体眼中CME的发生率,并观察了拉坦前列素、噻吗洛尔和防腐剂苯扎氯铵对细胞的形态损伤以及细胞因子和前列腺素(PG)合成指标的变化。基于这些研究结果,表明防腐剂会导致PGs和其他物质合成增加以及术后炎症加剧,我们提出了“人工晶状体性防腐剂黄斑病变”这一术语来描述由抗青光眼眼药水引起的CME。